Several AON physicians and leaders shared new cancer research at one of oncology’s most influential gatheringsFORT MYERS, Fla ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

Neuroendocrine colon cancer is a rare and aggressive form of cancer that starts in the cells of the colon with both nerve and ...